Cancer News

Immune Therapy Produces Anti-Cancer Responses in Advanced Cervical Cancer (04/24/2017)

Adoptive T-cell therapy (ACT) appears to provide anti-cancer responses among patients with advanced cervical cancer for whom standard therapy has stopped working. These results were published in the Journal of Clinical Oncology. The most common cause of cervical cancer is infection with particular strains of the human papillomavirus (HPV). As such, vaccinations against the virus …

Continue reading "Immune Therapy Produces Anti-Cancer Responses in Advanced Cervical Cancer"

Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated! (02/20/2017)

By Rachel Tompa / Fred Hutch News Service The most common sexually transmitted infection in the U.S. has a bit of a twist. It’s what’s known as a “subclinical infection” — those infected suffer no immediate consequences, but years later have vastly increased risks for at least six different types of cancer. That sleeper agent …

Continue reading "Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated!"

The HPV Vaccine Prevents Lesions That Could Cause Cervical Cancer by 50 Percent (10/13/2016)

A recent report published online Sept. 29 in the journal JAMA Oncology suggests that the vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, is more effective than previously thought. Human papillomaviruses consist of more than 100 different viruses. Some types of HPV cause warts on the hands or … Continue reading "The HPV Vaccine Prevents Lesions That Could Cause Cervical Cancer by 50 Percent"